Authors


Naoky Tsai, MD

Latest:

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.


Jeffrey Stewart, BA

Latest:

The Value of Specialty Pharmaceuticals - A Systematic Review

This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.



Susan M. Paddock, PhD

Latest:

Reducing Disparities Requires Multiple Strategies

Disparities in care are a complex issue requiring multiple strategies to solve, including approaches to improve the measurement of quality and reporting stratified performance estimates.


Yong Chen, MD, PhD

Latest:

Identifying Patients With Osteoporosis or at Risk for Osteoporotic Fractures

Identifying patients with osteoporosis or low bone mineral density and high risk for osteoporotic fractures is possible in administrative data using osteoporosis diagnoses and fracture risk profile.


Katherina M. Violette, BSN, RN

Latest:

No Time to Waste: Decreasing Patient Wait Times for Chemotherapy Administration Using Automated Prioritization in an Oncology Pharmacy System

Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.



Tomas Karpati, MD

Latest:

Identifying Frail Older People Using Predictive Modeling

The frailty determination of the Adjusted Clinical Groups“diagnoses based predictive model identified frail elders with moderate success compared with a validated screening questionnaire.


Yue Zhong, MD, PhD

Latest:

Potential Role of Network Meta-Analysis in Value-Based Insurance Design

This study illustrates that where clinical trials are lacking, network meta-analysis can provide valuable insights into the potential clinical and economic benefits of value-based insurance design.



Sandeep Palakodeti, MD, MPH

Latest:

Value Realization: An Unattained Challenge for Integrated Practice Units

As value realization eludes integrated practice units (IPUs), the authors examine 6 key value drivers for IPU teams to competitively drive volumes and hone their multidisciplinary competencies.


Brook Watts, MD

Latest:

Evaluating a Hepatitis C Quality Gap: Missed Opportunities for HCV-Related Care

Management of hepatitis C screening results can be optimized to ensure that patients receive high-quality care, reducing morbidity and costs related to the virus.


Mark B. Stephens, MD, MS

Latest:

Tests, Surgical Masks, Hospital Beds, and Ventilators: Add Big Data to the List of Tools to Fight the Coronavirus That Are in Short Supply

Big data could help identify potential clues about the immediate (and future) impact of coronavirus disease 2019, but it is in short supply.







Lisa J. Lash, PharmD

Latest:

Positive Predictive Values of ICD-9 Codes to Identify Patients With Stroke or TIA

This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.


Kristin N. Ray, MD, MS

Latest:

Opportunity Costs of Ambulatory Medical Care in the United States

An analysis of the opportunity cost associated with ambulatory medical care in the United States demonstrates substantial time costs for individuals and society.


Jessie S. Chambers, PhD

Latest:

Adjunctive Aripiprazole for Depression: Predictive Value of Early Assessment

In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.



Jonathan P. DeShazo, PhD, MPH

Latest:

EHRs in Primary Care Practices: Benefits, Challenges, and Successful Strategies

Small primary care practices reap some organizational and quality of care improvements from electronic health records; however, challenges persist in achieving meaningful use standards.


Adrian Towse, MA, MPhil

Latest:

What Do Pharmaceuticals Really Cost in the Long Run?

This study found that brand price at launch and generic entry overstates long-run average pharmaceutical costs, with and without accounting for medical cost offsets.


David M. Kent, MD, MSc

Latest:

Multiple Chronic Conditions in Type 2 Diabetes Mellitus: Prevalence and Consequences

This study's findings showed that diabetes care remained suboptimal among many patients with multiple chronic conditions and that patient outcomes varied by multimorbidity profile.


German Veselovskiy, MS

Latest:

Collection of Data on Race/Ethnicity and Language Proficiency of Providers

Health plans collect and use data on network providers' proficiency in languages other than English more commonly than race and ethnicity data on providers.


Brian J. Zikmund-Fisher, PhD

Latest:

Treatment Decisions for Complex Patients: Differences Between Primary Care Physicians and Midlevel Providers

Midlevel providers were significantly less likely than physicians to change blood pressure (BP) treatment for complex diabetic patients presenting with elevated BP at a single visit.




George L. Bakris, MD

Latest:

Optimizing Outcomes for Patients With CKD and T2DM

Steps that need to be taken to address unmet needs and optimize outcomes for patients who have chronic kidney disease and type 2 diabetes.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo